1933 Industries Inc C.TGIF

from BNN -

[jfogarty12]

Boston Beer wades into cannabis space with new infused teas
 

Boston Beer Co., the makers of Samuel Adams beer, has officially entered the cannabis arena. But they’re not compromising their beverage roots. The company announced Monday it launched a line of cannabis-infused tea with five milligrams of THC per can under the TeaPot brand. The new infused teas will be on Canadian shelves this July, part of an effort to test cannabis products here before building out a global brand, according to Bloomberg News. Cannabis drinks still account for about two per cent of the Canadian market, or roughly $81.3 million in sales over the past 12 months, according to industry data tracker Hifyre. Boston Beer said in a release that Windsor, Ont.-based Peak Processing Solutions will produce their new teas, while Entourage Health Corp. is responsible for distribution. - Written by Mitchell Consky
 

Rhode Island Governor signs bill to legalize recreational cannabis sales 
 

Rhode Island became the 19th state to permit recreational cannabis sales after Governor Dan McKee signed off on a legalization bill on Wednesday. The bill was signed after the majority of Rhode Island’s General Assembly voted in favour of the legislation on Tuesday. McKee’s office said their legalization efforts are intended to make the distribution of cannabis equitable, controlled and safe, according to the Associated Press. The bill legalizes the sale and possession of up to one ounce of marijuana for adults 21 and older, and allows residents to grow small amounts at home as long as personal home possession does not exceed ten ounces. Recreational sales are set to kick off this December with 33 cannabis retailers allowed in the state. Meanwhile, more than 80 per cent of Georgia voters supported legalizing recreational cannabis in a non-binding advisory question on the state’s primary election ballot, Cannabis Business Times reported. - Written by Mitchell Consky
 

Illicit market dominated by price, convenience: Study
 

Despite the legalization of non-medical cannabis in Canada and several U.S. states, displacing the illicit market continues to be complicated by price and convenience factors, according to a study published in the Journal of Studies on Alcohol and Drugs. The study incorporated survey data from an International Cannabis Policy Study where more than 11,650 cannabis consumers were asked to gauge their reasons behind purchasing from the illicit market. Canadians factored higher prices and inconvenience as a deterrence in legal purchase decisions, the study found. Consumers in provinces with expensive legal cannabis but accessible retail were more likely to report price as the primary barrier to moving out of the illicit space, and consumers in regions with inaccessible retail but lower price options cited inconvenience as the biggest factor in sticking with their dealer. - Written by Mitchell Consky